Sign In
NewsRadar

Medication safety system provider Mint Solutions secures €4.4 million

8 July 2014 14:37
By Tornado Staff

Dutch company Mint Solutions has raised €4.4 million in a Series A round led by Life Sciences Partners (LSP) and co-led by Seventure Partners with participation from existing investors. As part of this investment the company will relocate headquarters to the Netherlands.

Mint’s flagship MedEye product aims to prevent medication errors in hospitals and improve efficiency. Its hardware and software integrates into existing hospital infrastructure and helps hospitals and nurses ensure that all medications – from tablets to syringes – are correctly administered to the right patient at the right time. MedEye has been deployed in the Netherlands with further roll-outs planned there, the UK and Germany.

The company participated in the Startupbootcamp HighTechXL, an accelerator program in Eindhoven, The Netherlands. “We have also decided to set up our headquarters here to take advantage of the positive response we have been seeing over the last 12 months”, said Gauti Reynisson, CEO of Mint Solutions in a statement.



Related stories
Massive £50 million Series B round for UK-based Cell Medica
€6.3 million Series C for Humedics’ liver function diagnostic device
Big VC rounds for Ganymed and MISSION to fight cancer
Catalan medical diagnostics company STAT-Diagnostica gets €17 million
GME Medical Engineering adds BayBG to cap table


Up
Data


19,484
Tech investments
From our Online Data Service
12,534
VC-backed companies
From our Radar


Recent Deals


DATEAMOUNTSECTOR
Feb 24N/AConsumer applications
Feb 24€9.0MBiopharmaceuticals
Feb 24€0.4MInternet services
Feb 23€4.2MBusiness applications
Feb 23N/ADiagnostics
Feb 22€4.4MSecurity
Feb 20€2.0MWireless applications

For information on Europe's most extensive database on technology funding click here!

Events



Press Releases


Mar 2
High-Tech Gründerfonds Management
htgf portfolio company outfittery raises $20 million led by new inv...

Mar 2
Themis Bioscience
themis bioscience’s chikungunya vaccine study results published in ...

Mar 2
Alizé Pharma
alizé pharma launches phase ii clinical trial of azp-531 in prader-...

Mar 2
Implandata Ophthalmic Products (IOP)
implandata: first keratoprosthesis patient in europe receives perma...

Mar 2
Versatile Security
versatile security releases vsec:cms t4.0





About usContact usLegal Information
Copyright © 1999-2015
Emerging Technology Research Europe Inc. All rights reserved.